Literature DB >> 6415741

Studies on the pharmacology of d-amphetamine on maximal electroconvulsive seizure in young chicks.

G Osuide, C Wambebe, D Ngur.   

Abstract

d-Amphetamine protected young chicks against electroconvulsive seizure (ECS) in a dose-dependent manner in the dose range of 1-10 mg/kg. Reserpine pretreatment reduced ECS threshold and decreased the anticonvulsant effect of d-amphetamine in chicks. FLA-63 protected chicks against ECS and potentiated the anticonvulsant effect of d-amphetamine, whereas the dopamine antagonist pimozide antagonised the protective effect of d-amphetamine against ECS. Both the alpha-adrenoceptor antagonist phentolamine, and the serotonin antagonist cyproheptadine, had no significant influence on the anticonvulsant effect of d-amphetamine. d-Amphetamine significantly increased the levels of 5-hydroxytryptamine, noradrenaline and dopamine in the hyperstriatum, brain stem and optic tectum of the chick respectively. The present data suggests that brain dopamine may be the principal monoamine involved in the protective influence of d-amphetamine against ECS in young chicks.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6415741     DOI: 10.1007/BF00429004

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  A facilitation action of reserpine on the central nervous system.

Authors:  G CHEN; C R ENSOR; B BOHNER
Journal:  Proc Soc Exp Biol Med       Date:  1954-07

2.  Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

3.  The effects of apomorphine, (+)-amphetamine and L-dopa on maximal electroshock convulsions--a comparative study in the rat and mouse.

Authors:  G M McKenzie; F E Soroko
Journal:  J Pharm Pharmacol       Date:  1972-09       Impact factor: 3.765

4.  Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat.

Authors:  M Besson; A Cheramy; P Feltz; J Glowinski
Journal:  Brain Res       Date:  1971-09-24       Impact factor: 3.252

5.  Central monoamines and convulsine thresholds in mice and rats.

Authors:  M Kilian; H H Frey
Journal:  Neuropharmacology       Date:  1973-07       Impact factor: 5.250

6.  Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.

Authors:  H Corrodi; K Fuxe; B Hamberger; A Ljungdahl
Journal:  Eur J Pharmacol       Date:  1970-10       Impact factor: 4.432

7.  Dopamine agonists and audiogenic seizures: the relationship between protection against seizures and changes in monoamine metabolism.

Authors:  G M Anlezark; R W Horton; B S Meldrum
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

8.  Method for the rapid determination of norepinephrine, dopamine, and serotonin in the same brain region.

Authors:  D M Jacobowitz; J S Richardson
Journal:  Pharmacol Biochem Behav       Date:  1978-05       Impact factor: 3.533

9.  Neuropharmacological analysis of handling-induced seizures in gerbils.

Authors:  A R Schonfeld; S D Glick
Journal:  Neuropharmacology       Date:  1980-10       Impact factor: 5.250

10.  Depletion of brain noradrenaline, but not dopamine, by intracerebral 6-hydroxydopamine potentiates convulsions induced by electroshock.

Authors:  S T Mason; M E Corcoran
Journal:  J Pharm Pharmacol       Date:  1979-04       Impact factor: 3.765

View more
  1 in total

Review 1.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.